Table 3.

The relative expression of target mRNAs in the control, cisplatin, and 0.64 mg/mL SPS groups

Groups	Bcl-2	COX-2	Bax	Cleaved caspase-3
Control (24 h)	0.713 ± 0.031	0.638 ± 0.048	0.185 ± 0.043	0.262 ± 0.081
Control (48 h)	0.720 ± 0.196	0.592 ± 0.005	0.166 ± 0.121	0.321 ± 0.021
Control (72 h)	0.693 ± 0.232	0.799 ± 0.923	0.203 ± 0.056	0.301 ± 0.044
Cisplatin (24 h)	0.585 ± 0.055	0.513 ± 0.023*	0.481 ± 0.011*	0.477 ± 0.021*
Cisplatin (48 h)	0.451 ± 0.060*	0.416 ± 0.019*	0.566 ± 0.035*	0.681 ± 0.046*
Cisplatin (72 h)	0.281 ± 0.026*	0.264 ± 0.032*	0.762 ± 0.055*	0.872 ± 0.065*
SPS (24 h)	0.423 ± 0.055*	0.408 ± 0.023*	0.314 ± 0.011*	0.585 ± 0.034*
SPS (48 h)	0.345 ± 0.060*	0.222 ± 0.019*	0.426 ± 0.035	0.822 ± 0.081*
SPS (72 h)	0.201 ± 0.026*	0.118 ± 0.032*	0.582 ± 0.055*	1.031 ± 0.092*

SPS safflower polysaccharide. *P < 0.05 compared with the control group